Effects of hypoxia on MBF and forearm MVC
Variable/condition . | Saline . | . | Phentolamine . | . | ||
---|---|---|---|---|---|---|
. | Control . | Diabetes . | Control . | Diabetes . | ||
MBF (ml/min) | ||||||
Normoxia | 91.9 ± 21.1 | 77.9 ± 15.3 | 165.2 ± 40.1* | 175.9 ± 32.0* | ||
Hypoxia | 100.8 ± 28.2 | 100.2 ± 23.1 | 243.8 ± 66.8† | 250.2 ± 41.5† | ||
MVC (units) | ||||||
Normoxia | 102.9 ± 25.8 | 82.1 ± 16.4 | 186.7 ± 47.0* | 191.00 ± 35.0* | ||
Hypoxia | 105.8 ± 32.2 | 105.4 ± 24.9 | 266.0 ± 71.7 | 273.27 ± 47.5† |
Variable/condition . | Saline . | . | Phentolamine . | . | ||
---|---|---|---|---|---|---|
. | Control . | Diabetes . | Control . | Diabetes . | ||
MBF (ml/min) | ||||||
Normoxia | 91.9 ± 21.1 | 77.9 ± 15.3 | 165.2 ± 40.1* | 175.9 ± 32.0* | ||
Hypoxia | 100.8 ± 28.2 | 100.2 ± 23.1 | 243.8 ± 66.8† | 250.2 ± 41.5† | ||
MVC (units) | ||||||
Normoxia | 102.9 ± 25.8 | 82.1 ± 16.4 | 186.7 ± 47.0* | 191.00 ± 35.0* | ||
Hypoxia | 105.8 ± 32.2 | 105.4 ± 24.9 | 266.0 ± 71.7 | 273.27 ± 47.5† |
Data are means ± SE.
P is significant by Bonferroni-corrected post hoc t test versus saline trial within condition and subject group;
P is significant by Bonferroni-corrected post hoc t test, hypoxia versus normoxia.